Morbidity Challenges and Treatment Advances for Hemophilia Carriers: Focus on FIX/FVIII and Management of Both Types

This is a recorded version of the webinar on Morbidity Challenges and Treatment Advances for Hemophilia Carriers: Focus on FIX/FVIII and Management of Both Types that was presented live on Tuesday, December 19, 2017, at 12:00 PM – 1:00 PM EST. Please scroll down to view the archived webinar. 

Estimated Time to complete: 1 hour and 15 minutes 
Format: Archived Webinar

Program Description:

Webinar Faculty: Roshni Kulkarni, MD and Robert Sidonio, JR., MD, MSc 
Activity Medical Director: Andra H. James, MD, MPH

This Webinar has a special focus on the unique aspects of FIX/FVIII and their management and state-of-the-art treatments for female patients. It will include discussing the role of FIX/FVIII replacement in women with bleeding disorders and describing issues for both types of hemophilia carriers-hemophilia B and A. 

At the conclusion of this Webinar, participants will be able to:

1. Understand the importance of, and apply to practice, assessing patient history and experience as well as factor levels in carriers
2. Recognize and manage the range of bleeding and medical complications, including joint morbidity, that can occur in carriers of hemophilia B and hemophilia A
3. Recognize and manage the reproductive life-stage issues for hemophilia carriers, from menses through pregnancy and postpartum to menopause
4. Know and appropriately apply available new and state-of-the-science therapeutics/treatments in the optimal management of hemophilia B carriers
5. Know and appropriately apply available new and state-of-the-science therapeutics/treatments in the optimal management of hemophilia A carriers

Target Audience: Hematologists, pediatric/adolescent gynecologists, Ob/Gyn providers, nurse practitioners, and other healthcare providers

This Webinar is supported in part by an educational grant from Aptevo.

---